| Literature DB >> 33944822 |
Davide Di Mauro1, Angelica Fasano2, Mariannita Gelsomino3, Antonio Manzelli4.
Abstract
Laparoscopic splenectomy is nowadays widely performed for the treatment of benign and malignant diseases of the spleen. However, removing the spleen increases the risk of postoperative infections, therefore patients need long-life antibiotics. Advancement in surgical technique and instrumentation have led to the development of partial splenectomy, which is mainly indicated to treat localized lesions of the spleen. The main advantage is the preservation of the immune function, so that long-life prescription of antibiotics is no longer needed. The introduction of the laparoscopic approach to laparoscopic splenectomy seems to add further benefits, namely a faster recovery. We report two cases of benign splenic cysts, which were treated by laparoscopic partial splenectomy. Technical aspects on the parenchymal transection and data from the most recent literature are discussed as well.Entities:
Year: 2021 PMID: 33944822 PMCID: PMC8142767 DOI: 10.23750/abm.v92iS1.10186
Source DB: PubMed Journal: Acta Biomed ISSN: 0392-4203
Figure 1a.Computerized Tomography of the abdomen (coronal view).
Figure 1b.Computerized Tomography of the abdomen (axial view).
Figure 2a.Intraoperative view of the splenic cyst (arrow).
Figure 2b.Selective ligation of the superior vascular pedicle.
Figure 3.Splenic remnant after parenchymal transection
Published data on laparoscopic partial splenectomy (LPS)
| Ho8 | Cyst | 19 | F | Vascular control with endoscopic stapling device | Uneventful postoperatively. Hospital stay: 2 days | Follow-up: 30 months, no recurrence |
| Wang12 | Lymphangioma | 51 | F | Parenchimal transection with RFA† | Uneventful postoperatively. Hospital stay: 7 days | Follow-up: 3 months, no recurrence. Normal platelets count |
| Iimuro16 | Cyst | 23 | F | LPS and cyst unroofing | Uneventful postoperatively | Follow-up: 6 months, no recurrence. |
| Fan17 | Cyst | 30 | M | LPS | Uneventful postoperatively | Follow-up: 12 months, no recurrence. Normal platelets count |
| Hong19 | Cyst | 20 | M | Single-port technique. Parenchymal transection with ultrasonic scissors and electrocautery device | Uneventful postoperatively. Hospital stay: 4 days | Follow-up: 6 months, no recurrence. |
| Dudi-Venkata20 | Cyst | 19 | F | Parenchimal transection with RFA† | Uneventful postoperatively. Hospital stay: 4 days | Follow-up: 1 month, no recurrence. |
| Dudi-Venkata20 | Cyst | 56 | F | Parenchimal transection with rigid resectoscope and electro-coagulation | Uneventful postoperatively. Hospital stay: 4 days | Follow-up: 1 month, no recurrence. |
| Okano21 | Haemangioma | 37 | M | Hand-assisted technique. Parenchymal transection with electro-coagulation | Uneventful postoperatively. Hospital stay: 7 days | Follow-up: 5 months, no recurrence. Normal platelets count |
| Mignon22 | Hamartoma | 23 | F | Vascular control with selective splenic embolization. Delayed surgery | Not reported | Not reported |
| Hao26 | Wandering spleen | 24 | F | Parenchymal transection with RFA†, splenopexy | Uneventful postoperatively. Hospital stay: 11 days | Follow-up: 11 months, no recurrence. Normal platelets count |
| Gumbs27 | Cyst | 25 | F | Parenchimal transection with RFA† | Uneventful postoperatively. Hospital stay: 5 days | Follow-up: 1 month, no recurrence. Normal platelets count |
| Itamoto28 | Cyst | 19 | M | Parenchimal transection with RFA† | Uneventful postoperatively. Hospital stay: 9 days | Follow-up: 4 month, no recurrence. Normal platelets count |
†Radiofrequency ablation